Food and Drug Administration (FDA)-related drug information including new drugs approved by the FDA, new dosage forms and indications also approved by the FDA and agents awaiting approval from the FDA.BakerDirectorDanialDirectorE.DirectorEBSCO_AspHospital Pharmacy...
Newer agents called antisense oligonucleotides are now approved by the FDA. Antisense oligonucleotides are small pieces of DNA that are used to "mask" (cover up) the exon that needs to be skipped when making the dystrophin protein. This allows the rest of the gene to be be pieced together c...
The FDA approved Brukinsa (zanubrutinib) capsules from BeiGene USA, Inc., for the treatment of adult patients with mantle cell lymphoma who received at least one prior therapy. Brukinsa is the first novel anticancer drug developed by a Chinese company and approved by the FDA. It was granted...
To address this issue, last year we have initiated the mini-review series covering the most recent developments on the market of fluorinated drugs. The first review, under the title: “Fluorine-Containing Drugs Approved by the FDA in 2018” [7], was well received by the readers, generating ...
Wegovy, a GLP-1 receptor agonist injection from Novo Nordisk, is approved by the FDA for long-term weight management (in addition to diet and exercise) in:Adults and children aged 12 years and older with obesity Adults with overweight in the presence of at least one weight-related condition...
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. ...
" letters relate]]>doi:10.1310/hpj4406-509Baker, Danial E.Lippincott Williams and WilkinsHospital Pharmacy
Administration has previouslyapprovedmanydrugsforthe treatment of mild Alzheimer's disease, most [...] chinese.eurekalert.org chinese.eurekalert.org 此前FDA已批准了数种用于治疗轻度阿尔茨海默病的药物,多为胆碱酯酶抑制剂,但都未能从根本上治愈,且基本上是针对中早期患者。
A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs Eur. J. Clin. Pharmacol., 6 (2018), pp. 811-818 Google Scholar 28 N. Downing,et al. Regulatory review of new therapeutic agents — FDA versus EMA, 2011–...
Of the 37 drugs approved by the FDA in 2022, 24 (about 65%) were approved based on a single study. Four of the 37 drugs (about 11%) reported three or more studies before approval. Roughly half of the 413 studies available for analysis were classified as randomizedclinical trials, while...